The inhibition of CaMKK2 within myeloid cells suppresses tumor growth by increasing immune-stimulatory myeloid subsets and intra-tumoral accumulation of CD8+ T cells in TNBC [105]. This evidence concerns the gene CAMKK2 and neoplasm.